Versant Vantage II GP-GP, LLC's Net Worth

$0

Estimate Recalculated Nov 7, 2024 11:56AM EST

Who is Versant Vantage II GP-GP, LLC?

Versant Vantage II GP-GP, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Turnstone Biologics Corp., LENZ Therapeutics, Inc., Century Therapeutics, Inc., and Tempest Therapeutics, Inc..

SEC CIK

Versant Vantage II GP-GP, LLC's CIK is 0001839789

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LENZ Therapeutics, Inc. (GRPH) No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+245.21%
598.2K
—
—
842.16K
Mar 21
Form 4
+594.22%
14.05M
$17.00
—
16.42M
Jun 29
Form 3
—
0
—
—
0
No matching records found

Century Therapeutics, Inc. (IPSC) Snapshot price: $1.44

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-7.40%
-914.80K
$13.03
-$7,166,610.00
11.45M
Scheduled
Aug 9
Form 4
-1.43%
-179.00K
—
—
12.37M
Jan 31
Form 4
-2.87%
-371.00K
—
—
12.55M
Scheduled
Dec 23
Form 4
+357.29%
10.65M
$20.00
—
13.63M
Jun 22
Form 3
—
0
—
—
0
No matching records found

Tempest Therapeutics, Inc. (TPST) Snapshot price: $1.25

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-78.96%
-788.00K
$1.23
-$967,032.90
209.94K
Aug 8 - Aug 12
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Turnstone Biologics Corp. (TSBX) Snapshot price: $0.5884

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.38M
$12.00
—
3.38M
Jul 25
Form 3
—
0
—
—
0
No matching records found